Dupilumab reduces symptom burden in allergic rhinitis and suppresses allergen‐specific IgE production.Published in:Allergy, 2023, v. 78, n. 6, p. 1687, doi. 10.1111/all.15653By:Campion, Nicholas James;Doralt, Anna;Lupinek, Christian;Berger, Markus;Poglitsch, Katharina;Brugger, Jonas;Quint, Tamara;Gangl, Katharina;Sinz, Christoph;Bartosik, Tina;Liu, David Tianxiang;Landegger, Lukas David;Tu, Aldine;Stanek, Victoria;Berger, Uwe;Bangert, Christine;Schneider, Sven;Eckl‐Dorna, JuliaPublication type:Article